Article PDF
Avoid common mistakes on your manuscript.
Funding
This study was funded by PreludeDx, including expenses for institutional review boards (IRB) review and research costs associated with patient enrollment and physician surveys.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
Troy Bremer, Steve Shivers, Karuna Mittal, and Pat Whitworth are employees of and have stock options for PreludeDx. Troy Bremer is Chief Science Officer of PreludeDx, co-invented the technology and is named as an inventor of DCISionRT®. Frank Vicini, Chirag Shah, and Steven Narod are consultants for PreludeDx. All other co-authors were local principal investigators for the PREDICT Registry and their institutions received research funding to cover the costs of IRB review, patient enrollment and completion of case report forms. Frank Vicini is a consultant for Impedimed. Sachin Jhawar received grant funding from Varian Medical Systems to study the role of the oropharyngeal microbiome in HNC patients. Tari King declares speakers honoraria and compensated advisory board, Exact Sciences; Faculty PrecisCa Cancer Information Services. John Vargo declares Consulting Elsevier Clinical Pathways. Parul Barry declares El-Sevier Pathways Consultant; Talks for Oncolive/Varian on breast cancer and women in medicine; ACRO Board Member, Chair of ASTRO HEDI Education, Chair of WIMS Scientific Committee.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Shah, C., Whitworth, P., Vicini, F.A. et al. ASO Visual Abstract: The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT® PREDICT Study. Ann Surg Oncol (2024). https://doi.org/10.1245/s10434-024-15739-2
Published:
DOI: https://doi.org/10.1245/s10434-024-15739-2